TickerFactsScreenerDevelopers

Avalo Therapeutics, Inc. (AVTX) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2014: $10.30M2015: $8.57M2016: $5.56M2017: $14.95M2018: $49.34M2019: $15.11M2020: $19.19M2021: $57.13M2022: $44.28M2023: $13.69M2024: $17.70M2025: $33.41M$33.41M
2014Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$33.41M+88.8%
2024$17.70M+29.3%
2023$13.69M-69.1%
2022$44.28M-22.5%
2021$57.13M+197.7%
2020$19.19M+27.0%
2019$15.11M-69.4%
2018$49.34M+230.1%
2017$14.95M+168.7%
2016$5.56M-35.1%
2015$8.57M-16.8%
2014$10.30M—